Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

AAM-commissioned report: Biosimilars can save CMS $11.4B by 2027
AAM-commissioned report: Biosimilars can save CMS $11.4B by 2027
WASHINGTON — A new report from the Moran Co.
FDA approves Perrigo’s Exalgo extended-release generic
FDA approves Perrigo’s Exalgo extended-release generic
SILVER SPRING, Md.
The world is running out of antibiotics, WHO says
The world is running out of antibiotics, WHO says
(CNN) - Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday.
FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women
FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women
NEWARK, N.
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
London UK – 18 September 2017 -- GlaxoSmithKline plc (LSE/NYSE.
Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia
Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia
DUBLIN, Ireland and KING OF PRUSSIA, Pa.
Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy
Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy
PARIS--(BUSINESS WIRE)--September 19, 2017-- Regulatory News.
Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion
Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion
JERUSALEM--(BUSINESS WIRE)-- September 18, 2017 --Teva Pharmaceutical Industries Ltd.
WHO plans global war on cholera as Yemen caseload nears 700,000
WHO plans global war on cholera as Yemen caseload nears 700,000
GENEVA, Sept 18 (Reuters) - The World Health Organization will next month launch a strategy to stop cholera transmission by 2030, it said on Monday, as an unprecedented outbreak in Yemen raced...
Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER™ (amphetamine) Extended-Release Oral Suspension for the Treatment of ADHD in Patients 6 Years and Older
Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER™ (amphetamine) Extended-Release Oral Suspension for the Treatment of ADHD in Patients 6 Years and Older
DALLAS and FORT WORTH, TX, USA I September 15, 2017 I Neos Therapeutics, Inc.
Braeburn Announces FDA Acceptance with Priority Review of New Drug Application for CAM2038 Buprenorphine Depot for the Treatment of Opioid Use Disorder
Braeburn Announces FDA Acceptance with Priority Review of New Drug Application for CAM2038 Buprenorphine Depot for the Treatment of Opioid Use Disorder
PRINCETON, NJ, USA I September 18, 2017 I Braeburn Pharmaceuticals, Inc.
Drug industry on tenterhooks as Maryland price-gouging law nears
Drug industry on tenterhooks as Maryland price-gouging law nears
(Reuters) - As U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand